Svetlana Eckert

402 total citations
29 papers, 266 citations indexed

About

Svetlana Eckert is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Svetlana Eckert has authored 29 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 6 papers in Rheumatology. Recurrent topics in Svetlana Eckert's work include Multiple Sclerosis Research Studies (24 papers), Peripheral Neuropathies and Disorders (8 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Svetlana Eckert is often cited by papers focused on Multiple Sclerosis Research Studies (24 papers), Peripheral Neuropathies and Disorders (8 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Svetlana Eckert collaborates with scholars based in United States, Italy and Iran. Svetlana Eckert's co-authors include Bianca Weinstock‐Guttman, Dejan Jakimovski, Robert Zivadinov, Channa Kolb, Michael G. Dwyer, Osman Farooq, David Hojnacki, Saharnaz Nedjat, Ibrahim Abdollahpour and Mohammad Alì Mansournia and has published in prestigious journals such as Neurology, American Journal of Neuroradiology and Journal of Neurology.

In The Last Decade

Svetlana Eckert

26 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svetlana Eckert United States 11 214 86 48 43 29 29 266
Guillaume Mathey France 11 195 0.9× 95 1.1× 49 1.0× 42 1.0× 28 1.0× 31 351
Robert A Bermel United States 7 271 1.3× 124 1.4× 62 1.3× 63 1.5× 26 0.9× 12 349
Nik Krajnc Austria 11 178 0.8× 162 1.9× 40 0.8× 35 0.8× 38 1.3× 49 313
Kerstin Hellwig Germany 8 160 0.7× 60 0.7× 37 0.8× 34 0.8× 17 0.6× 33 238
Elvira Sbragia Italy 10 202 0.9× 83 1.0× 44 0.9× 48 1.1× 17 0.6× 25 261
Courtney Casserly Canada 7 181 0.8× 74 0.9× 52 1.1× 20 0.5× 23 0.8× 22 281
Seyed Mohammad Baghbanian Iran 9 132 0.6× 88 1.0× 24 0.5× 20 0.5× 40 1.4× 43 236
Tim Lotze United States 6 199 0.9× 182 2.1× 58 1.2× 25 0.6× 20 0.7× 11 305
Gleb Makshakov Russia 7 155 0.7× 93 1.1× 56 1.2× 29 0.7× 34 1.2× 21 214
Clémence Boutière France 9 257 1.2× 185 2.2× 46 1.0× 62 1.4× 32 1.1× 25 348

Countries citing papers authored by Svetlana Eckert

Since Specialization
Citations

This map shows the geographic impact of Svetlana Eckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svetlana Eckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svetlana Eckert more than expected).

Fields of papers citing papers by Svetlana Eckert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svetlana Eckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svetlana Eckert. The network helps show where Svetlana Eckert may publish in the future.

Co-authorship network of co-authors of Svetlana Eckert

This figure shows the co-authorship network connecting the top 25 collaborators of Svetlana Eckert. A scholar is included among the top collaborators of Svetlana Eckert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svetlana Eckert. Svetlana Eckert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kavak, Katelyn, Dejan Jakimovski, Svetlana Eckert, et al.. (2025). Resilience Among Caregivers of People With Multiple Sclerosis: Exploring the Influence of Personality Traits, Coping, and Caregiver Burden. International Journal of MS Care. 27(Q1). 15–15.
2.
Jakimovski, Dejan, Katelyn Kavak, Kara Patrick, et al.. (2024). Post-Partum Clinical and Patient-Reported Outcome Changes in Mothers with Multiple Sclerosis: Findings from the NAPPREMS Study. Medicina. 60(7). 1159–1159.
3.
Butler, Oisín, Bianca Weinstock‐Guttman, Dejan Jakimovski, et al.. (2024). Real-world effectiveness of disease-modifying therapies in older adults with multiple sclerosis. 3. 100094–100094. 1 indexed citations
4.
Mohebbi, Maryam, Murali Ramanathan, Niels Bergsland, et al.. (2024). Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis. Annals of Clinical and Translational Neurology. 12(2). 267–279. 3 indexed citations
5.
Zivadinov, Robert, Dejan Jakimovski, Jens Kühle, et al.. (2024). Neuroimaging assessment of facility-bound severely-affected MS reveals the critical role of cortical gray matter pathology: results from the CASA–MS case-controlled study. Journal of Neurology. 271(8). 4949–4962. 2 indexed citations
6.
7.
Jakimovski, Dejan, Katelyn Kavak, David Hojnacki, et al.. (2022). COVID-19 Vaccination in Multiple Sclerosis and Inflammatory Diseases: Effects from Disease-Modifying Therapy, Long-Term Seroprevalence and Breakthrough Infections. Vaccines. 10(5). 695–695. 15 indexed citations
8.
Jakimovski, Dejan, et al.. (2022). A prospective study to validate the expanded timed get-up-and-go in a population with multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(2). 3090462386–3090462386. 3 indexed citations
9.
Weinstock‐Guttman, Bianca, Channa Kolb, Dejan Jakimovski, et al.. (2022). Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives. Journal of Neurology. 270(2). 1095–1119. 3 indexed citations
10.
Jakimovski, Dejan, et al.. (2021). Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment. CNS Drugs. 36(1). 45–59. 41 indexed citations
11.
Jakimovski, Dejan, Svetlana Eckert, Robert Zivadinov, & Bianca Weinstock‐Guttman. (2021). Considering patient age when treating multiple sclerosis across the adult lifespan. Expert Review of Neurotherapeutics. 21(3). 353–364. 18 indexed citations
12.
Jakimovski, Dejan, Caila B. Vaughn, Svetlana Eckert, Robert Zivadinov, & Bianca Weinstock‐Guttman. (2020). Long-term drug treatment in multiple sclerosis: safety success and concerns. Expert Opinion on Drug Safety. 19(9). 1121–1142. 15 indexed citations
13.
Bergsland, Niels, Michael G. Dwyer, Jesper Hagemeier, et al.. (2020). Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis. American Journal of Neuroradiology. 41(9). 1577–1583. 14 indexed citations
14.
Benedict, Ralph H. B., David Hojnacki, Channa Kolb, et al.. (2020). Recovery of cognitive function after relapse in multiple sclerosis. Multiple Sclerosis Journal. 27(1). 71–78. 37 indexed citations
15.
Jakimovski, Dejan, Jesper Hagemeier, Deepa P. Ramasamy, et al.. (2020). Late onset multiple sclerosis is associated with more severe ventricle expansion. Multiple Sclerosis and Related Disorders. 46. 102588–102588. 14 indexed citations
16.
Ramasamy, Deepa P., Niels Bergsland, Dejan Jakimovski, et al.. (2020). Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. Multiple Sclerosis and Related Disorders. 47. 102653–102653. 20 indexed citations
17.
Vaughn, Caila B., et al.. (2019). <p>Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives</p>. Patient Related Outcome Measures. Volume 10. 373–384. 14 indexed citations
18.
Eckert, Svetlana, Bianca Weinstock‐Guttman, & David Hojnacki. (2019). A Case of an Aggressive Demyelinating NMO Spectrum Disorder-like Event in a Rheumatoid Arthritis Patient Treated with Tofacitinib (P1.2-016). Neurology. 92(15_supplement). 1 indexed citations
19.
Eckert, Svetlana, Bianca Weinstock‐Guttman, Channa Kolb, & David Hojnacki. (2018). Treatment of natalizumab-induced PML with cidofovir or CMX001 (brincidofovir) and mirtazapine (P5.380). Neurology. 90(15_supplement). 3 indexed citations
20.
Abdollahpour, Ibrahim, Saharnaz Nedjat, Mohammad Alì Mansournia, Svetlana Eckert, & Bianca Weinstock‐Guttman. (2018). Stress-full life events and multiple sclerosis: A population-based incident case-control study. Multiple Sclerosis and Related Disorders. 26. 168–172. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillaume Mathey Breakdown of academic impact, for papers by Robert A Bermel Breakdown of academic impact, for papers by Nik Krajnc Breakdown of academic impact, for papers by Kerstin Hellwig Breakdown of academic impact, for papers by Elvira Sbragia Breakdown of academic impact, for papers by Courtney Casserly Breakdown of academic impact, for papers by Seyed Mohammad Baghbanian Breakdown of academic impact, for papers by Tim Lotze Breakdown of academic impact, for papers by Gleb Makshakov Breakdown of academic impact, for papers by Clémence Boutière
Rankless by CCL
2026